"Reteplase plus abciximab and reteplase alone led to similar 30-day mortality rates in acute MI." by Steven Borzak

Selected Works of Steven Borzak, MD, FACC

Follow Contact

Article

Reteplase plus abciximab and reteplase alone led to similar 30-day mortality rates in acute MI.

ACP journal club (2002)

Steven Borzak, Florida Cardiovacular Group and Florida Cardiovascular Research, Atlantix, Florida, USA.

Link

Disciplines

Medicine and Health Sciences,
Cardiology and
Internal Medicine

Publication Date

March 1, 2002

DOI

10.7326/ACPJC-2002-136-2-042

Citation Information

Steven Borzak. "Reteplase plus abciximab and reteplase alone led to similar 30-day mortality rates in acute MI." ACP journal club Vol. 136 Iss. 2 (2002) p. 42 - 42
Available at: http://works.bepress.com/steven-borzak/74/